Wordt geladen...
The Efficacy of Synchronous Combination of Chemotherapy and EGFR TKIs for the First-Line Treatment of NSCLC: A Systematic Analysis.
The combination of chemotherapy and epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) currently has become the hotspot issue in the treatment of non-small lung cancer (NSCLC). This systematic review was conducted to compare the efficacy and safety of the synchronous combinati...
Bewaard in:
Hoofdauteurs: | , , , , , |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Public Library of Science (PLoS)
2015-01-01
|
Reeks: | PLoS ONE |
Online toegang: | http://europepmc.org/articles/PMC4540576?pdf=render |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|